Achieving NKF-K/DOQI™ bone metabolism and disease treatment goals with cinacalcet HCl
Top Cited Papers
- 1 February 2005
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 67 (2) , 760-771
- https://doi.org/10.1111/j.1523-1755.2005.67139.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- SevelamerNephron Clinical Practice, 2003
- Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidismKidney International, 2003
- THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Calcium Phosphate Metabolism and Cardiovascular Disease in Patients with Chronic Kidney DiseaseSeminars in Dialysis, 2003
- In Advanced Renal Failure, Dietary Phosphorus Restriction Reverses Hyperparathyroidism Independent of Changes in the Levels of CalcitriolNephron, 1993
- Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patientsKidney International, 1992
- Renal bone disease 1990: An unmet challenge for the nephrologistKidney International, 1990
- Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal FailureNew England Journal of Medicine, 1989
- Parathyroid hormone and 1,25(OH)2D3 in chronic renal failureKidney International, 1988
- A General Overview of Mantel-Haenszel Methods: Applications and Recent DevelopmentsAnnual Review of Public Health, 1988
- HYPERCALCÆMIA AFTER ORAL CALCIUM-CARBONATE THERAPY IN PATIENTS ON CHRONIC HÆMODIALYSISThe Lancet, 1973